Our Research & Development Strategy
Potential Indications
- Amyotrophic lateral sclerosis
- Ophthalmology
- Mitochondrial diseases
- Alzheimer’s disease
- Multiple sclerosis
- Parkinson’s disease
- Huntington’s disease
- Sarcopenia
- Ischemic stroke / cardiomyopathy
- Chemo-induced peripheral neuropathy
- Inflammatory bowel disease
- Metabolic Diseases
Pipeline Programs
- SARM1 Inhibitor
- RIPK1 Inhibitor
- NAMPT Activator
- Undisclosed I&I Target
- Therapeutic assets based on Brain Delivery Module platform
Clinical Directions
- Degenerative Diseases Affecting Longevity
- Diseases Requiring Supportive Care
- Rare Diseases
- Inflammatory, metabolic & immunological
diseases
Aging / Degeneration
Contributors
- Disrupted Energy Homeostasis
- Dysregulated Cell Death
- Uncontrolled Inflammation
Potential Indications
Pipeline Programs
Clinical Directions
Aging / Degeneration
Contributors
Research Project Video Gallery
Explore our latest research initiatives and scientific
breakthroughs through our video presentations.
breakthroughs through our video presentations.
SARM1 Inhibition
Explore the role of SARM1 in axonal degeneration and the therapeutic potential of SARM1 inhibition in neurodegenerative diseases.
RIPK1 Inhibition
Studying the role of RIPK1 in regulating cell death and inflammation for novel therapeutic approaches.
NAMPT Activation
Explore the critical role of NAMPT in energy homeostasis and the therapeutic potential of NAMPT activator in muscular degenerative diseases.